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Abstract
Purposes Clinical application of human embryonic stem cells
will be possible, when cell lines are created under xeno-free and
defined conditions. We aimed to establish methodologies for
parthenogenetic activation, culture to blastocyst and mechani-
cal isolation of the inner cell mass (ICM) using bovine oocytes,
as a model for derivation and proliferation of human embryonic
stem cells under defined xeno-free culture conditions.
Methods Cumulus-oocyte-complexes were in vitro matured
and activated using Ca2+Ionophore and 6-DMAP or in vitro
fertilized (IVF). Parthenotes and biparental embryos were
cultured to blastocysts, when their ICM was mechanically
isolated and placed onto a substrate of fibronectin in Stem-
Pro® medium. After attachment, primary colonies were left
to proliferate and stained for pluripotency markers, alkaline
phosphatase and Oct-4.
Results Parthenogenesis and fertilization presented signifi-
cantly different success rates (91 and 79 %, respectively) and
blastocyst formation (40 and 43 %, respectively). ICMs from
parthenogenetic and IVF embryos formed primary and ex-
panded colonies at similar rates (39% and 33 %, respectively).
Six out of eight parthenogenetic colonies tested positive for
alkaline phosphatase. Three colonies were analyzed for Oct-4
and they all tested positive for this pluripotency marker.
Conclusion Our data show that Ca2+ Ionophore, and 6-
DMAP are efficient in creating large numbers of blastocysts
to be employed as a model for human oocyte activation and
embryo development. After mechanical isolation, partheno-
getic derived ICMs showed a good rate of derivation in
fibronectin and Stem-Pro forming primary and expanded
colonies of putative embryonic stem cells. This methodolo-
gy may be a good strategy for parthenogenetic activation of
discarded human oocytes and derivation in defined condi-
tions for future therapeutic interventions.
Keywords Parthenogenesis . Embryonic stem cells .
Defined conditions
Introduction
Since the first derivation of a human embryonic stem cell
(hESC) line by Thomson and colleagues in 1998 [11],
several others have been established around the world.
However, the vast majority of the existing cell lines will
not be suitable for clinical use, because they were created in
the presence of animal components (also called xeno-com-
ponents), which may introduce undesired pathogens into the
Capsule Bovine parthenotes may be used as a model for the creation
of human embryonic stem cells derived and cultured under defined
conditions.
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cells, thus creating a serious future problem for human
health. On the other hand xeno-free hESC lines have already
been created. These cell lines were generated in presence of
human foreskin fibroblast feeders and cultured in defined
medium supplemented with human serum [4]. In addition,
two independend groups claim to have generated xeno-free
clinical grade hESC lines [6, 10], also using feeder layers for
derivation and thereafter culturing them in feeder-free systems.
The limited access to human embryos and the ethical issues
involved in manipulating them, greatly affects the experimen-
tal tests required to explore new substrates or matrices for the
creation of stem cell lines with clinical grade for therapeutic
use. Parthenogenetic activation is an acceptable and useful
means for derivation of new human embryonic stem cell lines
[7] for research and clinical applications. The bovine ovary
and oocytes are considered the best model for humans, be-
cause of their very similar physiology. Thus, we decided to
use this species to obtain large numbers of parthenogenetic
and biparental in vitro fertilized (IVF) embryos to test the
effectiveness of parthenogenetic activation and derivation for
the creation of embryonic stem cell lines in defined fibronectin
susbtrate and medium for cell culture.
Fibronectin is a high molecular weight glycoprotein pres-
ent in the extracellular matrix that binds to integrins on the
cell surface. It is secreted primarly by fibroblasts and it plays
a major role in cell adhesion, migration, differentiation,
wound healing and embryonic development. Fibronectin
exists as a protein dimer consisting of two monomers linked
by di-sulfite bonds. It has already been used as a substrate
for feeder-free human embryonic stem cell lines mainte-
nance [1, 9], but not for derivation.
This study represents the first stage of a project, which
involves the manufacturing of new defined susbtrates, based
on the fibronectin composition, which shall be used for
derivation and maintenance of bovine and human embryon-
ic stem cell lines under defined conditions.
Material and methods
Cumulus-oocyte-complexes (COCs) were aspirated from
ovarian follicles (3–6 mm diameter) and placed in groups
of 20 for in vitro maturation (IVM) in 70 μl medium drops
of maturation medium (Medium 199®, Vitrogen; Cravinhos,
SP, Brazil), at 38.5 °C, in 5 % CO2 in air for 22 h. COCs
with expanded cumulus cells were randomly selected for
parthenogenetic activation or IVF.
In vitro fertilization and embryo culture
IVF and embryo culture procedures followed the standard
methodology employed routinely in Vitrogen bovine IVF
laboratory [5]. Briefly, groups of 15 COCs were placed in
IVF medium (H199®, Vitrogen) supplemented with 6 % BSA
(Sigma-Aldrich, USA). Frozen sperm was prepared on a
discontinuous Percoll (Sigma-Aldrich) gradient and added to
COCs at a final concentration of 2.5 × 105/ml at day-0. On
day-1 the putative zygotes were transferred to cleavage medi-
um (CR4®, Vitrogen) and cultured to the expanded or hatch-
ing blastocyst stage on day-8 or 9. Fertilization rates were
calculated as the number of 2-cell embryos on day-2.
Parthenogenetic activation
Matured COCs were exposed to M-199 supplemented with
hyaluronidase (80 IU/ml) for 60 s and then gently pipetted in
medium H199. Denuded oocytes were left for an additional
period of 2–4 h in maturation medium, before exposure to
55μM Ionomycin (Sigma-Aldrich) in buffered H199medium
for 5 min. Oocytes were washed three times in the same
medium and transferred to CR4 medium supplemented with
2 mM 6-DMAP in a humidified atmosphere of 5 % CO2 in air
at 38.5 °C for 3.5 h, before culture in CR4 medium. Obser-
vations of embryonic development were performed at 48 h
and 196 h post-activation. Activation rates were calculated as
the number of 2-cell embryos on day-2 (48 h).
Inner cell mass isolation
Day-9 expanded or hatching blastocysts obtained by parthe-
nogenetic activation or IVF were manipulated in their cul-
ture dish with a pair of 32 G insulin needles under
stereoscope. The blastocysts that have not hatched were
gently removed from the zona pellucida by cutting it and
pressing the embryo out. The ICM was isolated from the
surrounding trophectodermal cells by holding the embryo
with one needle and carefully slicing the ICM away with the
other. We were careful to remove as much trophectodermal
cells as possible, without damaging the ICM.
Derivation and culture of putative bESC colonies
The isolated ICMs were placed onto a four-well dish (Nunc)
covered with fibronection (1 μg/ml) from human plasma
liquid (Invitrogen) and cultured in 1 ml of StemPro® medi-
um (Invitrogen) and basic fibroblast growth factor bFGF
(Gibco). Adherence to the substrate was assessed by gently
shaking the dishes in the next day. The putative primary
bESC colonies that continued proliferating were maintained
in StemPro and mechanically cut in small pieces for passag-
ing after 6–7 days of culture. The cell clumps were distrib-
uted into new wells containing fresh fibronectin and
StemPro. Cultures were performed in a humidified atmo-
sphere of 5 % CO2 in air at 38.5
o.C. Medium was changed
every 2 days, by replacing 500 μl of the original volume
with fresh medium.
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Alkaline phosphatase staining
Alkaline phosphatase (AP) staining was performed using a
commercially available kit (Sigma) and carried out according
to manufacturer’s instructions. Briefly, grown and well spread
colonies were fixed in 4 % paraformaldehyde for 10 min at
room temperature washed and covered with the stain solution
(napthol/fast red violent solution). The stain was incubated for
15 min in the dark at room temperature, rinsed and examined
for red stained stem cell colonies under bright field using an
inverted microscope (Nikon Eclipse TS100).
Immunofluorescence analysis of octamer-binding transcription
factor 4 (OCT-4) expression
For Oct-4 detection, anti-mouse Oct-4 IgG (1:100; Novus
Biological, USA) and goat anti-mouse IgG secondary anti-
bodies (1:500) were used. Nuclei were counterstained with
4,6-diamidino- 2-phenylindole (DAPI). Cells were analyzed
using Fluorescent microscope (Nikon Eclipse TS100).
Statistical analysis
The results of each treatment, that is, IVF or parthenogenetic
activation were evaluated by Chi-square test (X2). A level of
5 % significance was used.
Overall, we performed 10 replicates of the IVF and
parthenogenetic activation experiments up to blastocyst cul-
ture, without derivation. Out of these 10 replicates, seven
included derivation and culture of the putative primary ESC
colonies.
Results
A total of 4158 COCs were retrieved and placed for IVM
before IVF or parthenogenetic activation. Table 1 shows the
results of activation, fertilization blastocyst formation and
derivation. There were significant differences between IVF
and parthenogenesis in terms of 2-cell cleavage rates and
blastocyst formation (P<0.05). However, the number of ICMs
that attached to the substrate and formed a primary colony did
not differ significantly between the two treatments, IVF and
parthenogenetic activation. We were not able to maintain the
putative bESCells for more than two passages due to labora-
tory workload and financial restrictions.
One hundred and forty parthenotes and 45 IVF ICM
adhered to fibronectin, and 39 % and 33 % of these pre-
sented cell outgrowth within 2 days, respectively. They
further proliferated forming monolayers of cells within 6–
7 days of culture. The putative bESC colonies exhibited
clear borders and characteristic ESC morphology: they were
small and round with low cytoplasm:nucleus ratio (Fig. 1).
The cell layers underwent two passages before we stopped
them from continuing to proliferate.
Out of the thirteen putative bESC colonies that were tested
for alkaline phosphatase, eight parthenote and five IVF
Table 1 Parthenogenetic and IVF embryonic development and derivation on fibronectin and Stem Pro medium
Treatement No. repetitions No. COCs Day-2
Cleavage (%)
Day-7
Blastocyst (%)
No. of Blastocysts
placed onto
fibronectin
No. repetitions No. of ICM
adhered to
fibronectin (%)
No. of expanded
primary colonies
(%)
Parthenogenesis 10 3312 3011 (91)a 1209 (40)a 350 7 140 (40)a 54 (39)a
IVF 10 846 674 (79)b 363 (43)b 90 7 45 (50)a 15 (33)a
*Values with different superscripts within columns are significant different (p<0.05)
Fig. 1 Putative bovine parthenogenetic embryonic stem cell colony
Fig. 2 Putative bovine primary embryonic stem cell colony stained for
alkaline phosphatase
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showed a positive reaction (Fig. 2). Also, three out of three
parthenote putative bESC colonies tested positive for Oct-4.
Discussion
This study presents a simple and efficient methodology for
the production of bovine parthenotes and isolation of ICMs
for derivation and generation of putative bESC colonies
using a defined substrate and medium, which may be ap-
plied as a model to work with human discarded oocytes. The
newness of our work is that we successfully achieved good
rates of derivation of primary bESC colonies from parthe-
nogentic and IVF embryos in a defined commercially avail-
able medium, StemPro and a defined substrate, fibronectin.
We believe that these protocols may be extrapolated for
human oocytes that failed to fertilize in Assisted Reproduc-
tion cycles to generate new hESC lines under similar de-
fined conditions.
The present activation methodology is not new [2,
12–14], but it showed a considerable higher rate of activa-
tion and development to blastocyst, when compared with
previous reports using a similar protocol [15] and they agree
with data reported in other studies on bovine parthenogesis
[8, 12]. The successful manual isolation of the ICMs
allowed us to develop an efficient protocol for derivation
of bovine ESCs using defined components as fibronectin
and StemPro for culture. Forty percent of the parthenoge-
netic ICMs and 50 % of the IVF ICMs attached to the
substrate. From the adhered ICMs we obtained 39 % and
33 % of expanded colonies, respectively, suggesting that
cells interacted satisfactory with fibronectin and maintained
their proliferative capacity forming typical primary stem
cell-like colonies. These results contrast with previously
reported data, where 15 mechanically dissected bovine ICMs
plated ontomouse embryonic feeder cells did not adhere to the
substrate and disappeared in few days [3]. In addition, assays
for pluripotency markers presented very clear results indicat-
ing that the parthenogenetic and IVF colonies created by these
methodologies were primary bESCs.
One important point to make is that in our experiments,
we did not observe any difference in developmental dynam-
ics between parthenogenetic and IVF embryos, neither be-
tween the primary and the expanded colonies derived from
both groups of embryos. This information reassures us to
start studies with human parthenotes under the same defined
conditions aiming to obtain clinical-grade parthenogetic
ESC lines, once we have all the setting for this end.
Parthenogenetic activation is a useful method to create
embryos for experimental and clinical work in humans,
because their use overcomes the ethical concerns related to
the manipulation of human biparental embryos generated
for reproductive purposes. It has already been shown that
parthenotes may become an important source of blastocysts
to derive human embryonic stem cells (hESCs), which may
benefit a considerable part of the human population as they
are immunocompatible to the oocyte donors [7]. In this
regard, our study adds useful information on protocols to
produce high numbers of parthenogenetic blastocysts for
derivation and a successful means of ICM isolation and
culture under defined conditions.
We were not able to continue the culture of the putative
bESC due to laboratory workload and financial restrictions.
Our aim is to follow up these results using the same proto-
cols and new chemically defined matrices to produce well-
established bovine and human embryonic cell lines. We are
aware that bovine embryonic cell lines are not easy to keep
in culture and possibly, it will be more challenging to
maintain them proliferating under defined conditions, than
human ESCs. In a recent work, Jin and colleagues [16]
compared different methods of cell passaging, feeder cell
layers and medium conditions for bovine embryonic stem
cell-like cells maintenance. They found that a murine em-
bryonic fibroblast feeder layer is more suitable for embry-
onic stem cell-like cells continued proliferation, than bovine
embryonic fibroblasts. However, feeder cells represent a
potential source of putative pathogens and thus a component
we shall not try to employ in our work as others did [4, 6,
10].
In conclusion, we believe that the present results show
that the combination of fibronectin and StemPro was effec-
tive in producing a good number of primary putative bESC
colonies, which were able to proliferate and demonstrate
pluripotency markers after extended culture. Despite the
announcement of the creation of the first clinical-grade
hESC line [6], with potential therapeutic applications, there
is still the need for more research to develop protocols that
are economically viable and repeatable under different lab-
oratory settings and also safe, for clinical use.
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